Cairo - Mubasher: The stock of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) has successfully regained its upward momentum following a sharp correction after reaching its all-time high near EGP 4.81 in February 2026, indicating a gradual return of buying power.
The stock opened Monday’s session with a notable rise, enabling it to break through a key resistance level at EGP 4.62.
This supports the potential for further gains towards EGP 4.80. Surpassing the all-time high is a positive factor that could pave the way for an extension of the upward movement towards the EGP 4.90-4.97 range.
On the other hand, maintaining the EGP 4.52 level remains crucial for sustaining the positive short-term outlook, which supports the possibility of retesting the all-time resistance in the coming period.
Technical indicators point to positive performance, with the Relative Strength Index (RSI) moving above the neutral level, while the Moving Average Convergence Divergence (MACD) is showing positive signals.
Price Action Summary
Rameda's stock began trading in January 2025 with a sideways movement and low trading volumes.
Starting in February, the price broke out of this sideways movement with high trading volumes, rising from EGP 2.39 to EGP 3.60 in May.
The price then entered a sideways, fluctuating movement without breaking through key levels from May until January 2026.
It finally broke out of this sideways range, accompanied by increased trading volumes, reaching a historic high in February 2026 near EGP 4.81.
Disclaimer
This analysis is based on technical analysis tools and reflects a comprehensive analytical view that may vary depending on interpretation methods.
It does not constitute a direct recommendation to buy or sell, nor an invitation to make investment decisions. This is intended solely for monitoring and study purposes. Investment decisions are the sole responsibility of the investor, based on their financial situation and investment goals.
